Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico. More Details
Slightly overvalued with limited growth.
Share Price & News
How has Acadia Healthcare Company's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ACHC is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: ACHC's weekly volatility (8%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: ACHC exceeded the US Healthcare industry which returned 14.2% over the past year.
Return vs Market: ACHC exceeded the US Market which returned 19.6% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Acadia Healthcare Company's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 days ago | Simply Wall StCan Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Improve Its Returns?
2 weeks ago | Simply Wall StIs There An Opportunity With Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) 23% Undervaluation?
3 months ago | Simply Wall StAcadia Healthcare Company, Inc. (NASDAQ:ACHC) Delivered A Weaker ROE Than Its Industry
Is Acadia Healthcare Company undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ACHC ($50.74) is trading below our estimate of fair value ($62.38)
Significantly Below Fair Value: ACHC is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: ACHC is poor value based on its PE Ratio (44.4x) compared to the US Healthcare industry average (29.8x).
PE vs Market: ACHC is poor value based on its PE Ratio (44.4x) compared to the US market (21x).
Price to Earnings Growth Ratio
PEG Ratio: ACHC is poor value based on its PEG Ratio (2.1x)
Price to Book Ratio
PB vs Industry: ACHC is good value based on its PB Ratio (1.7x) compared to the US Healthcare industry average (3.5x).
How is Acadia Healthcare Company forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ACHC's forecast earnings growth (20.9% per year) is above the savings rate (2%).
Earnings vs Market: ACHC's earnings (20.9% per year) are forecast to grow slower than the US market (21.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ACHC's revenue (6% per year) is forecast to grow slower than the US market (10.3% per year).
High Growth Revenue: ACHC's revenue (6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ACHC's Return on Equity is forecast to be low in 3 years time (8.8%).
How has Acadia Healthcare Company performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ACHC has a large one-off loss of $106.9M impacting its September 30 2020 financial results.
Growing Profit Margin: ACHC became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: ACHC's earnings have declined by 15.8% per year over the past 5 years.
Accelerating Growth: ACHC has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: ACHC has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (21.4%).
Return on Equity
High ROE: ACHC's Return on Equity (3.9%) is considered low.
How is Acadia Healthcare Company's financial position?
Financial Position Analysis
Short Term Liabilities: ACHC's short term assets ($756.4M) exceed its short term liabilities ($601.3M).
Long Term Liabilities: ACHC's short term assets ($756.4M) do not cover its long term liabilities ($3.8B).
Debt to Equity History and Analysis
Debt Level: ACHC's debt to equity ratio (117.2%) is considered high.
Reducing Debt: ACHC's debt to equity ratio has reduced from 127.2% to 117.2% over the past 5 years.
Debt Coverage: ACHC's debt is not well covered by operating cash flow (19%).
Interest Coverage: ACHC's interest payments on its debt are not well covered by EBIT (2.4x coverage).
What is Acadia Healthcare Company current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ACHC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ACHC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ACHC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ACHC's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ACHC's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Debbie Osteen (64 yo)
Ms. Debra K. Osteen, also known as Debbie, has been Chief Executive Officer and Director of Acadia Healthcare Company, Inc. since December 16, 2018. Ms. Osteen led Universal Health Services, Inc’s Behavior...
CEO Compensation Analysis
Compensation vs Market: Debbie's total compensation ($USD7.72M) is above average for companies of similar size in the US market ($USD5.01M).
Compensation vs Earnings: Debbie's compensation has been consistent with company performance over the past year.
|CEO & Director||2.08yrs||US$7.72m||0.23% |
|Chief Financial Officer||8.5yrs||US$1.63m||0.087% |
|Executive Vice President of Operations||1.5yrs||US$2.11m||0.067% |
|Executive VP||9.92yrs||US$1.53m||0.23% |
|Executive Vice President of Finance||1.42yrs||US$1.15m||0.061% |
|Director of Investor Relations||no data||no data||no data|
|Chief Quality & Compliance Officer||no data||no data||no data|
|Senior Vice President of Strategic Affairs||2yrs||no data||no data|
|Senior Vice President of Government Relations||no data||no data||no data|
|Chief Medical Officer||no data||no data||no data|
|Chief Development Officer||no data||no data||no data|
|President of the Clinic - Acadia Vermilion Hospital||25yrs||no data||no data|
Experienced Management: ACHC's management team is considered experienced (2.1 years average tenure).
|CEO & Director||2.08yrs||US$7.72m||0.23% |
|Independent Chairman & Lead Director||2.08yrs||US$337.01k||0.74% |
|Independent Director||8yrs||US$299.01k||0.033% |
|Independent Director||9.75yrs||US$314.51k||0.088% |
|Independent Director||1.08yrs||US$200.00k||0.013% |
|Independent Director||8.17yrs||US$282.01k||0.037% |
|Independent Director||4.67yrs||US$297.01k||0.025% |
|Independent Director||9yrs||US$289.51k||0.046% |
|Independent Director||0.25yr||no data||0.0060% |
Experienced Board: ACHC's board of directors are considered experienced (4.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Acadia Healthcare Company, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Acadia Healthcare Company, Inc.
- Ticker: ACHC
- Exchange: NasdaqGS
- Founded: 2005
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: US$4.515b
- Shares outstanding: 88.99m
- Website: https://www.acadiahealthcare.com
Number of Employees
- Acadia Healthcare Company, Inc.
- 6100 Tower Circle
- Suite 1000
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ACHC||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||Nov 2011|
|7RA||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Nov 2011|
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare faciliti...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/01/19 00:16|
|End of Day Share Price||2021/01/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.